Moritoh, Yusuke http://orcid.org/0000-0001-5252-6264
Abe, Shin-ichi http://orcid.org/0000-0003-4104-749X
Akiyama, Hiroki http://orcid.org/0000-0003-4553-2011
Kobayashi, Akihiro http://orcid.org/0000-0002-0375-3388
Koyama, Ryokichi
Hara, Ryoma http://orcid.org/0000-0003-0647-5560
Kasai, Shizuo http://orcid.org/0000-0002-7309-842X
Watanabe, Masanori
Article History
Received: 11 November 2020
Accepted: 15 July 2021
First Online: 11 August 2021
Competing interests
: All authors are employees of SCOHIA PHARMA, Inc. SCOHIA has been granted by Takeda Pharmaceutical Company an exclusive worldwide license to research, develop, manufacture, commercialize, or otherwise exploit SC-919 as a drug candidate for human use under the patent WO2018182051.